A Vision of Future Treatment in Chagas Heart Disease

[...]to counteract the pathogenic potency of beta1-AABs, but presently only directed to beta1-AAB-positive patients with idiopathic dilated cardiomyopathy, new treatment strategies are under study that focus on beta1-AAB removal via an apheresis technique or drug treatment for in vivo beta1-AAB neut...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2014-03, Vol.63 (10), p.1027-1027
Main Authors: Wallukat, Gerd, PhD, Haberland, Annekathrin, PhD, Schimke, Ingolf, PhD
Format: Article
Language:English
Subjects:
Cardiology
Cardiomyopathy
Cardiovascular
Cardiovascular disease
Chagas Disease - epidemiology
Heart
Humans
Internal Medicine
Medical research
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]to counteract the pathogenic potency of beta1-AABs, but presently only directed to beta1-AAB-positive patients with idiopathic dilated cardiomyopathy, new treatment strategies are under study that focus on beta1-AAB removal via an apheresis technique or drug treatment for in vivo beta1-AAB neutralization (2).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2013.08.1660